Tissue Regenix Group plc (LON:TRX – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 60.24 ($0.73) and traded as low as GBX 57 ($0.69). Tissue Regenix Group shares last traded at GBX 57.03 ($0.69), with a volume of 4,648 shares traded.
Tissue Regenix Group Price Performance
The stock’s 50 day simple moving average is GBX 58.26 and its 200-day simple moving average is GBX 60.16. The company has a debt-to-equity ratio of 35.69, a quick ratio of 2.36 and a current ratio of 3.74. The firm has a market cap of £40.67 million, a price-to-earnings ratio of -5,709.00 and a beta of 1.61.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Featured Stories
- Five stocks we like better than Tissue Regenix Group
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What is MarketRank™? How to Use it
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Are Penny Stocks a Good Fit for Your Portfolio?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
